Using the tool of proteomic differential displays, we have identified that many plasma metabolic and inflammatory proteins such as THBS2, NGAL and PIP levels might be good biomarkers for the correlation to T2DM with nephropathy. This evidence concerns the gene LCN2 and type 2 diabetes mellitus.